# Oryzon Genomics S.A. (ORYZF)

> Healthcare · ES · Reports in EUR

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ORYZF)

## Price

| Indicator | Value |
| --- | --- |
| Market Cap | € 275.38M |

## Valuation

Widest P/E window this company has the history to fill: 12 years. Shorter windows are still computed; longer ones are left empty rather than padded.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.11 |
| Liabilities / Eq | 0.25 |
| Current Ratio | 1.95 |

## Other views

- [Charts](https://sponda.capital/en/ORYZF/charts.md)
- [Fundamentals](https://sponda.capital/en/ORYZF/fundamentals.md)
- [Compare](https://sponda.capital/en/ORYZF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.